Sharon Shiraga

2.1k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

Sharon Shiraga is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sharon Shiraga has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Sharon Shiraga's work include Chronic Myeloid Leukemia Treatments (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Mast cells and histamine (3 papers). Sharon Shiraga is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Mast cells and histamine (3 papers). Sharon Shiraga collaborates with scholars based in United States, Germany and Grenada. Sharon Shiraga's co-authors include Michael C. Heinrich, Diana Griffith, Arin Schroeder, Grazyna Adamus, Patina M. Harrell, Christopher L. Corless, Laura McGreevey, Ajia Town, Troy Bainbridge and Marcus M. Schittenhelm and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sharon Shiraga

18 papers receiving 1.5k citations

Hit Papers

PDGFRA Mutations in Gastrointestinal Stromal Tumors: Freq... 2005 2026 2012 2019 2005 200 400 600

Peers

Sharon Shiraga
Comparison fields: 5 of 90
  • Gastroenterology 570
  • Pulmonary and Respiratory Medicine 546
  • Surgery 418
  • Molecular Biology 308
  • Hematology 272
Replace Marie‐Claude Babron with:
Marie‐Claude Babron France
Anna L. Mitchell United Kingdom
Syed A. Morshed United States
Christopher N. Vlangos United States
Hiroki Chiba Japan
Kevin X. Liu United States
Daniëlle Majoor‐Krakauer Netherlands
John M. Slopis United States
Susanna Ruggero Italy
Francesco Boin United States
Marie‐Claude Babron France View profile →
Citations per field, relative to Sharon Shiraga
Sharon Shiraga · 1×
Citations per year, relative to Sharon Shiraga
Sharon Shiraga · 1×

Countries citing papers authored by Sharon Shiraga

Since Specialization
Citations

This map shows the geographic impact of Sharon Shiraga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Shiraga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Shiraga more than expected).

Fields of papers citing papers by Sharon Shiraga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Shiraga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Shiraga. The network helps show where Sharon Shiraga may publish in the future.

Co-authorship network of co-authors of Sharon Shiraga

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Shiraga. A scholar is included among the top collaborators of Sharon Shiraga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Shiraga. Sharon Shiraga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
# Work Indexed citations
1 0
2 2
3 2
4 1
5 3
6 14
7 1
8 12
9 19
10 58
11
Dasatinib and rapamycin synergistically inhibit the proliferation of cells expressing oncogenic KIT kinase via global inhibition of AKT-dependent signaling
1
12 87
13 47
14 168
15 378
16
PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib breakdown →
626
17 6
18 38
19 89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026